ATE240351T1 - Rib-protein, ein oberflächenprotein welches immunität gegen viele streptococcus-stämme der gruppe b verleiht, reinigungsverfahren für das rib-protein, testsatz und pharmazeutische zusammenstellung (arznei) - Google Patents

Rib-protein, ein oberflächenprotein welches immunität gegen viele streptococcus-stämme der gruppe b verleiht, reinigungsverfahren für das rib-protein, testsatz und pharmazeutische zusammenstellung (arznei)

Info

Publication number
ATE240351T1
ATE240351T1 AT94911348T AT94911348T ATE240351T1 AT E240351 T1 ATE240351 T1 AT E240351T1 AT 94911348 T AT94911348 T AT 94911348T AT 94911348 T AT94911348 T AT 94911348T AT E240351 T1 ATE240351 T1 AT E240351T1
Authority
AT
Austria
Prior art keywords
protein
rib
pharmaceutical composition
many group
immunity against
Prior art date
Application number
AT94911348T
Other languages
English (en)
Inventor
Gunnar Lindahl
Margareth Stalhammar-Carlemalm
Lars Stenberg
Original Assignee
Gunnar Lindahl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gunnar Lindahl filed Critical Gunnar Lindahl
Application granted granted Critical
Publication of ATE240351T1 publication Critical patent/ATE240351T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT94911348T 1993-03-19 1994-03-21 Rib-protein, ein oberflächenprotein welches immunität gegen viele streptococcus-stämme der gruppe b verleiht, reinigungsverfahren für das rib-protein, testsatz und pharmazeutische zusammenstellung (arznei) ATE240351T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9300234 1993-03-19
PCT/SE1994/000246 WO1994021685A1 (en) 1993-03-19 1994-03-21 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition

Publications (1)

Publication Number Publication Date
ATE240351T1 true ATE240351T1 (de) 2003-05-15

Family

ID=20388669

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94911348T ATE240351T1 (de) 1993-03-19 1994-03-21 Rib-protein, ein oberflächenprotein welches immunität gegen viele streptococcus-stämme der gruppe b verleiht, reinigungsverfahren für das rib-protein, testsatz und pharmazeutische zusammenstellung (arznei)

Country Status (17)

Country Link
US (1) US5869064A (de)
EP (1) EP0656014B1 (de)
JP (1) JP3976334B2 (de)
KR (1) KR100331358B1 (de)
CN (1) CN1046291C (de)
AT (1) ATE240351T1 (de)
CA (1) CA2158658A1 (de)
DE (1) DE69432658T2 (de)
DK (1) DK0656014T3 (de)
ES (1) ES2194024T3 (de)
HU (1) HU217582B (de)
NZ (1) NZ263275A (de)
PT (1) PT656014E (de)
SG (1) SG47049A1 (de)
SI (1) SI0656014T1 (de)
WO (1) WO1994021685A1 (de)
ZA (1) ZA941958B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015889A (en) * 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
TR200002437T2 (tr) 1998-02-20 2000-11-21 Biochem Pharma Inc. B grubu streptococcus antijenleri.
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
ATE297995T1 (de) * 1998-12-22 2005-07-15 Microscience Ltd Aussermembranproteine, ihre gene, und deren verwendung
EA004444B1 (ru) * 1998-12-22 2004-04-29 Майкросайенс Лимитед Гены и белки и их применение
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
KR100802198B1 (ko) * 1998-12-23 2008-02-11 샤이어 바이오켐 인코포레이티드 신규한 스트렙토코커스 항원
GB9910375D0 (en) 1999-05-05 1999-06-30 Lindahl Gunnar Vaccine composition
US20070059687A1 (en) * 2001-05-31 2007-03-15 Tsuneya Ohno Process for evaluating phagocytotic function and use thereof
JP3934605B2 (ja) * 2001-05-31 2007-06-20 扶桑薬品工業株式会社 感染症原因微生物の検出および同定のための改良された方法
WO2003068813A2 (en) * 2002-02-11 2003-08-21 Shire Biochem Inc Group b streptococcus antigen
WO2006086330A2 (en) * 2005-02-08 2006-08-17 Id Biomedical Corporation Of Quebec C.O.B. As Glaxosmithkline Biologicals North America Pharmaceutical compositions
PT2144924T (pt) 2007-04-16 2016-08-17 Minervax Aps Vacina de proteína de fusão
EP3365003A1 (de) 2015-10-21 2018-08-29 Minervax APS Immunogenes fusionsprotein
WO2017114655A1 (en) 2015-12-30 2017-07-06 Minervax Aps Immunogenic complex for eliciting protective immunity against group b streptococcus
US20200254083A1 (en) 2017-06-16 2020-08-13 Glaxosmithkline Biologicals Sa Method of treatment
BR112022008761A2 (pt) 2019-11-22 2022-07-26 Glaxosmithkline Biologicals Sa Dosagem e administração de uma vacina de glicoconjugado de sacarídeo
EP4066854A1 (de) 2021-03-29 2022-10-05 MinervaX Immunogenes fusionsprotein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US4772584A (en) * 1986-05-23 1988-09-20 Cleary Paul P Inhibitor of C5a-mediated chemotaxis
EP0367890A1 (de) * 1988-11-11 1990-05-16 HighTech Receptor AB Protein Arp, mit Bindungsaktivität für Immunglobulin A sowie dessen Klonierung und Expression
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
IL95578A (en) * 1989-09-15 1998-08-16 Gen Hospital Corp Conjugate vaccine formed from a polysaccharide and a c protein of b-streptococcus
CA2103551A1 (en) * 1991-03-29 1992-09-30 Ervin Faulmann Method for production of an iga binding protein derived from group b streptococci

Also Published As

Publication number Publication date
SI0656014T1 (en) 2003-12-31
JPH09500092A (ja) 1997-01-07
ES2194024T3 (es) 2003-11-16
DE69432658D1 (de) 2003-06-18
CN1119442A (zh) 1996-03-27
JP3976334B2 (ja) 2007-09-19
EP0656014B1 (de) 2003-05-14
US5869064A (en) 1999-02-09
NZ263275A (en) 1997-07-27
PT656014E (pt) 2003-09-30
AU6389194A (en) 1994-10-11
HUT72841A (en) 1996-05-28
AU681130B2 (en) 1997-08-21
HU9501993D0 (en) 1995-08-28
WO1994021685A1 (en) 1994-09-29
DE69432658T2 (de) 2004-04-08
CN1046291C (zh) 1999-11-10
HU217582B (hu) 2000-02-28
DK0656014T3 (da) 2003-08-11
SG47049A1 (en) 1998-03-20
CA2158658A1 (en) 1994-09-29
EP0656014A1 (de) 1995-06-07
ZA941958B (en) 1995-01-27
HK1008825A1 (en) 1999-05-21
KR100331358B1 (ko) 2002-08-13
KR960701096A (ko) 1996-02-24

Similar Documents

Publication Publication Date Title
DE69432658D1 (de) Rib-protein, ein oberflächenprotein welches immunität gegen viele streptococcus-stämme der gruppe b verleiht, reinigungsverfahren für das rib-protein, testsatz und pharmazeutische zusammenstellung (arznei)
DE69735715D1 (de) Cholin-bindendes Protein, welches als gegen Pneumokokken gerichtetes Vakzin verwendet wird
DE69636487D1 (de) Zusammensetzungen zur Immuntherapie und Diagnose von Tuberculosis
ATE479756T1 (de) Streptococcus pneumoniae-antigene und impfstoffe
WO2001062893A3 (en) Compounds and methods for diagnosis and immunotherapy of tuberculosis
DE3783191D1 (de) Verfahren und mittel zur herstellung eines proteins mit der gleichen igg-spezifizitaet wie protein g.
BR9809445A (pt) Polipeptìdeo compreendendo uma porção imunogênica de um antìgeno de m. tubercolosis, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processos para indução de imunidade protetora em um paciente, processo de detecção de tuberculose em um paciente,e , kit de diagnóstico.
SE9602496D0 (sv) Method and means for producing a fibrinogen binding protein and its use in biotechnology
DE69534186D1 (de) Impfstoff gegen Streptokokkeninfektionen der Gruppe A
WO1997035982A3 (en) Monocyte chemotactic protein-5 materials and methods
NO922421L (no) Collagenbindende protein, samt fremstilling derav
BR9908476A (pt) Peptìdeo, composição terapêutica, e, processo para conferir imunidade protetora a um paciente, contra a infecção de s. pneumoniae
WO1995020658A3 (en) Diagnosis and treatment of infections due to streptococci and enterococci
BR8906960A (pt) Processo para obtencao de peptidio,molecula dna,composicao farmaceutica,processo para utilizacao de peptidio,intermediario de peptidio-resina e reagente de diagnostico
AU645078B2 (en) Antigenic proteins of (borrelia burgdorferi)
AR010517A1 (es) Compuestos y metodos para la inmunoterapia y diagnostico de tuberculosis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0656014

Country of ref document: EP

REN Ceased due to non-payment of the annual fee